Form D · Other Health Care
Organoid Therapeutics, Inc.
Irwin, PA · CIK 0001807052
Offering snapshot reported Mar 19, 2020 · SEC filing
- Reported sold
- $445K Offering amount: $1.5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 19, 2020 | Initial | $445,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-363242
Source: Form D, filed Mar 19, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Denver Faulk | Director, Executive |
| Ricardo Londono | Director, Executive |
| David S Smith | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
10096 Stella De Oro Dr.
Irwin, PA, 15642
Irwin, PA, 15642